G*e
2 楼
忘了:不要追高,这个道理吗?为什么看到涨了这么多,才想跳进去?
n*3
3 楼
谢谢!不是刚刚出消息说FDA建议批准吗?之前怕不批不敢买。
a*1
5 楼
The risk is much lower than two days ago at 4.
The odds of commercial success is much larger than that of FDA approval and
than most people expected.
This device is totally different from NKTR/PFE product and one of the
reasons they failed FDA approval twice before was to make sure the device
can be a commercial success.
The total insulin market is more than $5B and this one certainly has its
niche. I would assume 10% penetration for the first year and 30% 5 year. It
is not that hard to justify $3B market cap at this stage.
【在 n*****3 的大作中提到】
: is it too risky to buy it now at 7.xx?
The odds of commercial success is much larger than that of FDA approval and
than most people expected.
This device is totally different from NKTR/PFE product and one of the
reasons they failed FDA approval twice before was to make sure the device
can be a commercial success.
The total insulin market is more than $5B and this one certainly has its
niche. I would assume 10% penetration for the first year and 30% 5 year. It
is not that hard to justify $3B market cap at this stage.
【在 n*****3 的大作中提到】
: is it too risky to buy it now at 7.xx?
n*3
6 楼
看大千有人分析说前景看好。那我等等它回调再买吧。
j*8
8 楼
don,t but now
l*i
10 楼
今天涨后,后边BASH的就要来了,再加上有可能增发,还是等几天比较好
相关阅读